BURGESS ERNEST G III 4
4 · NATIONAL HEALTHCARE CORP · Filed May 6, 2022
Insider Transaction Report
Form 4
BURGESS ERNEST G III
Director
Transactions
- Award
Option to Purchase Common Stock [2022 Grant]
2022-05-05+7,500→ 7,500 totalExercise: $69.19From: 2023-05-05Exp: 2027-05-04→ Common Stock (7,500 underlying)
Holdings
- 7,500
Option to Purchase Common Stock
Exercise: $72.92From: 2017-05-09Exp: 2022-05-08→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock
Exercise: $61.90From: 2018-05-03Exp: 2023-05-02→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock
Exercise: $77.92From: 2019-05-09Exp: 2024-05-08→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock
Exercise: $64.64From: 2021-05-07Exp: 2025-05-06→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock
Exercise: $71.64From: 2022-05-06Exp: 2026-05-05→ Common Stock (7,500 underlying) - 91,644
Shares of Common Stock
Footnotes (1)
- [F1]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).